12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

RSV-F vaccine: Phase I started

Novavax began a double-blind, Phase I trial to evaluate 2 dose levels of a single intramuscular injection of RSV-F vaccine with and without an aluminum phosphate adjuvant given...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >